- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A207
- A2-A208
- A1-A213
- A1-A214
- A1-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-14 (Sunday)
A1-A109
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:06 |
Machine learning-based MRI radiomics in predicting survival after concurrent TACE with Lenvatinib plus PD-1 inhibitors for unresectable HCC: a multicenter study |
Chi Zhang | Sichuan Cancer Hospital, China |
| 2 | 08:16-08:22 |
Lenvatinib and PD-1 inhibitors plus Hepatic Arterial Infusion Chemotherapy as First-line Treatment for Hepatocellular Carcinoma with High Tumor Burden and Portal Vein Tumor Thrombus: a Target Trial Emulation Study (CHANCE 2416) |
Jia-Xi Liu | The First Affiliated Hospital of China Meical University, China |
| 3 | 08:24-08:30 |
Early Response Evaluation of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Triphasic Computed Tomography |
Nasr ullah Yaqoob | Aria Institute of Medical Sciences Balochistan, Pakistan |
| 4 | 08:40-08:46 |
Balloon - TACE : Novel technique for enhanced drug deposition in HCC |
Aayush Mathur | AVBRH, India |
| 5 | 08:48-08:54 |
Long-term Outcome and Temporal Trend after TACE for HCC: A Pooled Analysis of Individual-Patient Data and Global Systematic Review |
Dong-Dong Xia | Xi'an International Medical Center Hospital, China |
| 6 | 08:56-09:02 |
Pharmacokinetics of Idarubicin in Plasma and Liver Tissues of VX2 Hepatocellular Carcinoma Rabbits after Transarterial Chemoembolization with EqualSphere Drug-Eluting Microspheres |
Zhe-Yu Jiang | Affiliated Hospital of Guizhou Medical University, China |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 10:00-10:06 |
Hepatic Hilar Plexus Block as Sole Anesthesia for Microwave Ablation of Hepatocellular Carcinoma—A Paradigm Shift in Pain Control |
Vaibhav Yadav | Sir Gangaram Hospital, New Delhi, India |
| 2 | 10:08-10:14 |
Radiation exposure in Transarterial Chemoembolization for Hepatocellular Carcinoma in China: A National Retrospective Study |
Ke-Hua Suo | Cancer Hospital Chinese Academy of Medical Sciences, China |
| 3 | 10:16-10:22 |
Anti-inflammatory coupled anti-angiogenic airway stent effectively suppresses tracheal instents restenosis |
Ya-Nan Zhao | The First Affiliated Hospital of Zhengzhou University, China |
| 4 | 10:24-10:30 |
A Triple-Responsive Dual Near-Infrared Fluorescent Probe for Concurrent Monitoring of Hydrogen Peroxide, Viscosity, and Polarity |
Nuo Xu | Southeast University, China |
| 5 | 10:40-10:46 |
Chinese Expert Concern and Consensus on Applications of Artificial Intelligence in Clinical Cancer Imaging |
Han Wang | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China |
| 6 | 10:48-10:54 |
Transarterial Chemoembolization (TACE) Combined with Systemic Therapy versus TACE Alone or Systemic Therapy Alone for CNLC IIIa Hepatocellular Carcinoma: A Real-World, Inverse Probability of Treatment Weighting-Based Cohort Study |
Jue-Fan Li | Southeast University, China |
| 7 | 10:56-11:02 |
Prognostic value of body composition in patients with unresectable hepatocellular carcinoma receiving TACE combined with targeted therapy and immunotherapy |
Qing-Xia Shen | Zhongda Hospital, Southeast University, China |
| 8 | 11:04-11:10 |
Asia's Accelerating Burden of Early-Onset Pancreatic Cancer: A 32-Year Global Comparative Analysis Using GBD 2021 |
Xiao-Xin Ye | Chinese PLA General Hospital, China |
